Published in Laryngoscope on June 01, 2006
Melanoma of the oral cavity: pathogenesis, dermoscopy, clinical features, staging and management. J Dermatol Case Rep (2014) 0.91
Head and neck melanoma. ISRN Surg (2012) 0.89
Update on primary head and neck mucosal melanoma. Head Neck (2015) 0.88
Mucosal melanoma of the head and neck. Exp Ther Med (2011) 0.83
Survival in Sinonasal Melanoma: A Meta-analysis. J Neurol Surg B Skull Base (2012) 0.80
Expression of Sox10 and c-kit in sinonasal mucosal melanomas arising in the Chinese population. Head Neck Pathol (2012) 0.79
Spindle cell amelanotic lesion of the tongue: a diagnostic and therapeutic challenge. Indian J Surg (2012) 0.77
Sinonasal Melanoma: A Case Report and Literature Review. Case Rep Oncol Med (2017) 0.75
The Prognostic Role of the Surgical Approach and Adjuvant Therapy in Operable Mucosal Melanoma of the Head and Neck. Clin Exp Otorhinolaryngol (2016) 0.75
Head and neck melanoma (excluding ocular melanoma): United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol (2016) 0.75
Clinical analysis of 29 cases of nasal mucosal malignant melanoma. Oncol Lett (2015) 0.75
Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol (2010) 7.29
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med (2007) 7.05
Is there a role for surgery for patients with a complete clinical response after chemoradiation for esophageal cancer? An intention-to-treat case-control study. Ann Surg (2013) 2.70
American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol (2006) 2.68
Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial. J Clin Oncol (2012) 2.62
Salvage stereotactic reirradiation with or without cetuximab for locally recurrent head-and-neck cancer: a feasibility study. Int J Radiat Oncol Biol Phys (2012) 1.83
Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer. J Clin Oncol (2012) 1.74
Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer. Radiother Oncol (2013) 1.68
Radiotherapy alone for primary Merkel cell carcinoma. Arch Dermatol (2003) 1.55
Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer. Lancet Oncol (2009) 1.37
Image-guided robotic stereotactic body radiation therapy for liver metastases: is there a dose response relationship? Int J Radiat Oncol Biol Phys (2011) 1.26
Cancer of the larynx. Crit Rev Oncol Hematol (2003) 1.19
Multivariate analysis of risk factors for wound infection in head and neck squamous cell carcinoma surgery with opening of mucosa. Study of 260 surgical procedures. Oral Oncol (2005) 1.16
Population pharmacokinetics of erlotinib and its pharmacokinetic/pharmacodynamic relationships in head and neck squamous cell carcinoma. Eur J Cancer (2009) 1.12
Cancer of the oropharynx. Crit Rev Oncol Hematol (2002) 1.09
Prognostic factors affecting local control of hepatic tumors treated by Stereotactic Body Radiation Therapy. Radiat Oncol (2012) 1.01
Stereotactic body radiation therapy for hepatocellular carcinoma: prognostic factors of local control, overall survival, and toxicity. PLoS One (2013) 1.00
Image-guided robotic stereotactic radiation therapy with fiducial-free tumor tracking for lung cancer. Radiat Oncol (2012) 0.95
A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases. Radiat Oncol (2012) 0.93
Transoral robotic surgery: role in the management of upper aerodigestive tract tumors. Head Neck (2011) 0.92
Extracranial stereotactic radiotherapy: preliminary results with the CyberKnife. Onkologie (2009) 0.92
Initial multi-institutional experience with transoral robotic surgery. Otolaryngol Head Neck Surg (2012) 0.92
Prognosis of hypercalcemia in aerodigestive tract cancers: study of 136 recent cases. Oral Oncol (2005) 0.91
Head and neck soft tissue sarcomas of adult: prognostic value of surgery in multimodal therapeutic approach. Oral Oncol (2004) 0.91
Robotic image-guided reirradiation of lateral pelvic recurrences: preliminary results. Radiat Oncol (2011) 0.89
Exclusive low-dose-rate brachytherapy in 279 patients with T2N0 mobile tongue carcinoma. Int J Radiat Oncol Biol Phys (2005) 0.86
Palliative chemotherapy does not improve survival in metastatic esophageal cancer. Oncology (2010) 0.86
Radiotherapy alone for Merkel cell carcinoma: a comparative and retrospective study of 25 patients. J Am Acad Dermatol (2011) 0.85
Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102. J Clin Oncol (2007) 0.85
Organ and voice preservation in advanced laryngeal cancer. Acta Otolaryngol (2002) 0.83
Oral metronomic cyclophosphamide in elderly with metastatic melanoma. Invest New Drugs (2009) 0.83
"Sufficient life expectancy": an amazing inclusion criterion in cancer phase II-III trials. J Clin Oncol (2009) 0.83
Image-based response assessment of liver metastases following stereotactic body radiotherapy with respiratory tracking. Radiat Oncol (2013) 0.82
Psychosocial factors involved in delayed consultation by patients with head and neck cancer. Head Neck (2005) 0.82
Ineffectiveness of ¹⁸F-fluorodeoxyglucose positron emission tomography in the evaluation of tumor response after completion of neoadjuvant chemoradiation in esophageal cancer. Ann Surg (2013) 0.82
[Frequency of genetic diseases and cancer antecedents in 493 adults with visceral or soft tissue sarcomas]. Bull Cancer (2003) 0.82
Radiochemotherapy of locally advanced anal canal carcinoma: prospective assessment of early impact on the quality of life (randomized trial ACCORD 03). Radiother Oncol (2008) 0.82
Adjuvant radiation therapy in metastatic lymph nodes from melanoma. Radiat Oncol (2011) 0.82
A simple predictive model for postoperative mortality after head and neck cancer surgery with opening of mucosa. Oral Oncol (2006) 0.81
Head and neck cancer surgery in the elderly--does age influence the postoperative course? Oral Oncol (2009) 0.80
[Radiation-induced skin reactions (except malignant tumors)]. Bull Cancer (2003) 0.80
Is preoperative chemoradiation with paclitaxel and carboplatin a new standard of treatment for esophageal cancer? Int J Radiat Oncol Biol Phys (2013) 0.80
Prognostic significance of wound infections following major head and neck cancer surgery: an open non-comparative prospective study. Support Care Cancer (2004) 0.79
Factors determining length of the postoperative hospital stay after major head and neck cancer surgery. Oral Oncol (2007) 0.78
Previous chemotherapy as a predictor of wound infections in nonmajor head and neck surgery: Results of a prospective study. Head Neck (2004) 0.78
International Consortium on Head and Neck Cancer Awareness (ICOHANCA). Oral Oncol (2007) 0.78
Treatment of laryngeal cancer: the permanent challenge. Expert Rev Anticancer Ther (2004) 0.77
Cetuximab in the management of locoregionally advanced head and neck cancer: expanding the treatment options? Eur J Cancer (2010) 0.76
Docetaxel in the treatment of squamous cell carcinoma of the head and neck. Ther Clin Risk Manag (2008) 0.76
Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome. BMC Cancer (2013) 0.76
Cetuximab with concurrent chemoradiation for esophagogastric cancer: in regard to Safran et al. (Int J Radiat Oncol Biol Phys 2008;70:391-395). Int J Radiat Oncol Biol Phys (2008) 0.75
Reply to R. Glynne-Jones et al. J Clin Oncol (2013) 0.75
Have we established a stereotactic body radiotherapy regimen for liver metastases? J Clin Oncol (2009) 0.75
The impact of a total laryngectomy on the patients' quality of life. Eur Arch Otorhinolaryngol (2011) 0.75
Esophageal Adenocarcinoma: Impact of a Large Hiatal Hernia on Outcomes After Surgery. Ann Surg (2016) 0.75
Transoral minimally invasive robotic surgery for carcinoma of the pharynx and the larynx: a new approach. Anticancer Drugs (2011) 0.75
Functional and sensitive outcomes after tongue reconstruction: about a series of 30 patients. Oral Oncol (2011) 0.75
[Induction chemotherapy and larynx preservation: is such practice useful?]. Bull Cancer (2002) 0.75
[Merkel cell carcinoma: current diagnosis and treatment]. Bull Cancer (2008) 0.75
Anatomic variations of cervical internal carotid artery course: surgical implications. J Otolaryngol (2003) 0.75
External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma. Int J Radiat Oncol Biol Phys (2006) 0.75
Survival prognostic factors for lateral bucco-pharyngeal junction squamous cell carcinoma. Eur Arch Otorhinolaryngol (2007) 0.75